Tag Archives: Personal Genome Diagnostics

December, 2016

• 19 December

  PGDx Launches CancerSELECT 125 Test for Pan-Cancer Tumor Profiling

  

  BALTIMORE, Dec. 19, 2016 /PRNewswire/ — Personal Genome Diagnostics Inc. (PGDx), a leading provider of advanced cancer genome testing products and services, today announced the launch of its CancerSELECT™ 125 test for pan-cancer tumor profiling. CancerSELECT 125 identifies clinically actionable and functionally important sequence mutations and structural alterations across multiple …

  Share

  • Facebook
  • Twitter
  • LinkedIn

April, 2015

• 16 April

  Study Finds Inaccuracies with Tumor-Only Gene Sequencing

  

  New cancer tests that only sequence alterations in a patient’s tumor could lead to a significant number of patients receiving inappropriate treatment, a new study suggests. A new study, published in Science Translational Medicine, conducted by scientists from Personal Genome Diagnostics, Inc. (PGDx) and Johns Hopkins Kimmel Cancer Center, found …

  Share

  • Facebook
  • Twitter
  • LinkedIn